Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis in cancer.

Naoyo Nishida1, Hirohisa Yano, Takashi Nishida

  • 1Department of Pathology, Research Center of Innovative Cancer Therapy of the 21 Century, COE Program for Medical Science, Kurume University School of Medicine, Fukuoka, Japan. naoji@med.kurume-u.ac.jp

Vascular Health and Risk Management
|March 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Claudin-2 extracellular loop 1-mimetic peptides functionally inhibit combined hepatocellular-cholangiocarcinoma cells.

Scientific reports·2026
Same author

Attenuation imaging and hepatorenal index composite score for the noninvasive assessment of hepatic steatosis in chronic liver disease: a prospective multicenter study.

Journal of medical ultrasonics (2001)·2026
Same author

Diagnostic Impact of Two-Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective Study.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same author

Multiple Coronary Artery Aneurysms and Coronary-Pulmonary Artery Fistula Associated with Vieussens' Arterial Ring.

Surgical case reports·2026
Same author

Ventricular Septal Perforation Associated with Takotsubo Syndrome and Its Pathogenic Mechanisms.

Surgical case reports·2026
Same author

[A Case of Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer Successfully Treated with Capivasertib and Fulvestrant in Late-Line Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

New blood vessel growth (angiogenesis) fuels cancer spread. While anti-angiogenic therapies show promise, they haven't improved long-term survival, necessitating combined treatment strategies.

Area of Science:

  • Oncology
  • Vascular Biology

Background:

  • Tumor growth and metastasis depend on vascularization for nutrients and oxygen.
  • Angiogenesis (new blood vessel formation) and lymphangiogenesis (new lymphatic vessel formation) are critical processes.
  • Angiogenic factors, including activators and inhibitors, regulate vascular network expansion.

Purpose of the Study:

  • To review the role of angiogenesis in cancer progression.
  • To discuss the development and limitations of anti-angiogenic therapies.
  • To highlight the need for novel cancer treatment strategies.

Main Methods:

  • Literature review of angiogenesis and anti-angiogenic therapies.
  • Analysis of the impact of angiogenic factors on tumor aggressiveness.
  • Evaluation of current clinical outcomes of anti-angiogenic treatments.

Related Experiment Videos

Main Results:

  • Angiogenic factor expression correlates with tumor aggressiveness.
  • Anti-angiogenic therapies have been administered to numerous patients.
  • Current anti-angiogenic treatments have not significantly improved long-term cancer survival.

Conclusions:

  • Despite theoretical potential, anti-angiogenic agents alone are insufficient for long-term cancer survival.
  • A comprehensive treatment strategy combining anti-angiogenic agents with conventional therapies is urgently needed.
  • Further research into combined modalities is essential for effective cancer control.